JINS HOLDINGS Inc. (JNDOF)
USD 22.75
(0.0%)
USD 22.75
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 12.51 Billion JPY | -45.15% |
| 2022 | 22.81 Billion JPY | -2.29% |
| 2021 | 23.35 Billion JPY | -4.76% |
| 2020 | 24.51 Billion JPY | 410.75% |
| 2019 | 4.8 Billion JPY | 13.23% |
| 2018 | 4.23 Billion JPY | -25.17% |
| 2017 | 5.66 Billion JPY | 0.87% |
| 2016 | 5.61 Billion JPY | 20.18% |
| 2015 | 4.67 Billion JPY | 26.99% |
| 2014 | 3.67 Billion JPY | -2.41% |
| 2013 | 3.77 Billion JPY | 0.04% |
| 2012 | 3.76 Billion JPY | 66.85% |
| 2011 | 2.25 Billion JPY | 137.36% |
| 2010 | 951.77 Million JPY | -32.54% |
| 2009 | 1.41 Billion JPY | 166.47% |
| 2008 | 529.43 Million JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 11.87 Billion JPY | -5.07% |
| 2024 Q3 | 11.8 Billion JPY | 0.88% |
| 2024 Q2 | 11.7 Billion JPY | -1.51% |
| 2023 Q2 | 12.1 Billion JPY | -45.84% |
| 2023 Q3 | 12.16 Billion JPY | 0.51% |
| 2023 Q4 | 12.51 Billion JPY | 2.89% |
| 2023 FY | 12.51 Billion JPY | -45.15% |
| 2023 Q1 | 22.34 Billion JPY | -2.07% |
| 2022 Q4 | 22.81 Billion JPY | 2.6% |
| 2022 FY | 22.81 Billion JPY | -2.29% |
| 2022 Q1 | 22.56 Billion JPY | -3.37% |
| 2022 Q3 | 22.23 Billion JPY | -1.0% |
| 2022 Q2 | 22.46 Billion JPY | -0.46% |
| 2021 Q3 | 22.59 Billion JPY | -3.63% |
| 2021 Q4 | 23.35 Billion JPY | 3.34% |
| 2021 Q1 | 23.32 Billion JPY | -4.84% |
| 2021 FY | 23.35 Billion JPY | -4.76% |
| 2021 Q2 | 23.44 Billion JPY | 0.51% |
| 2020 FY | 24.51 Billion JPY | 410.75% |
| 2020 Q1 | 2.96 Billion JPY | -38.21% |
| 2020 Q4 | 24.51 Billion JPY | 4.49% |
| 2020 Q3 | 23.46 Billion JPY | -18.24% |
| 2020 Q2 | 28.69 Billion JPY | 867.6% |
| 2019 Q2 | 2.83 Billion JPY | -39.16% |
| 2019 Q3 | 3.24 Billion JPY | 14.39% |
| 2019 Q4 | 4.8 Billion JPY | 48.01% |
| 2019 Q1 | 4.66 Billion JPY | 9.93% |
| 2019 FY | 4.8 Billion JPY | 13.23% |
| 2018 FY | 4.23 Billion JPY | -25.17% |
| 2018 Q2 | 4.2 Billion JPY | -29.66% |
| 2018 Q3 | 4.1 Billion JPY | -2.33% |
| 2018 Q4 | 4.23 Billion JPY | 3.16% |
| 2018 Q1 | 5.98 Billion JPY | 5.58% |
| 2017 Q4 | 5.66 Billion JPY | 49.24% |
| 2017 Q1 | 3.58 Billion JPY | -36.22% |
| 2017 Q2 | 3.68 Billion JPY | 2.99% |
| 2017 Q3 | 3.79 Billion JPY | 2.9% |
| 2017 FY | 5.66 Billion JPY | 0.87% |
| 2016 FY | 5.61 Billion JPY | 20.18% |
| 2016 Q4 | 5.61 Billion JPY | 22.19% |
| 2016 Q3 | 4.59 Billion JPY | -3.87% |
| 2016 Q2 | 4.78 Billion JPY | 9.21% |
| 2016 Q1 | 4.37 Billion JPY | -6.31% |
| 2015 Q1 | 3.42 Billion JPY | -6.84% |
| 2015 FY | 4.67 Billion JPY | 26.99% |
| 2015 Q2 | 3.24 Billion JPY | -5.24% |
| 2015 Q3 | 3.03 Billion JPY | -6.43% |
| 2015 Q4 | 4.67 Billion JPY | 53.72% |
| 2014 Q4 | 3.67 Billion JPY | 28.9% |
| 2014 FY | 3.67 Billion JPY | -2.41% |
| 2014 Q3 | 2.85 Billion JPY | -9.72% |
| 2014 Q2 | 3.16 Billion JPY | -9.01% |
| 2014 Q1 | 3.47 Billion JPY | -7.83% |
| 2013 Q2 | 3.65 Billion JPY | 5.15% |
| 2013 Q3 | 3.52 Billion JPY | -3.41% |
| 2013 Q4 | 3.77 Billion JPY | 6.94% |
| 2013 Q1 | 3.47 Billion JPY | -7.89% |
| 2013 FY | 3.77 Billion JPY | 0.04% |
| 2012 Q4 | 3.76 Billion JPY | 9.79% |
| 2012 Q2 | 2.42 Billion JPY | 1.52% |
| 2012 Q1 | 2.38 Billion JPY | 5.64% |
| 2012 Q3 | 3.43 Billion JPY | 41.71% |
| 2012 FY | 3.76 Billion JPY | 66.85% |
| 2011 FY | 2.25 Billion JPY | 137.36% |
| 2011 Q3 | 1.79 Billion JPY | 57.15% |
| 2011 Q4 | 2.25 Billion JPY | 25.53% |
| 2011 Q1 | 1.49 Billion JPY | 57.59% |
| 2011 Q2 | 1.14 Billion JPY | -23.65% |
| 2010 FY | 951.77 Million JPY | -32.54% |
| 2010 Q4 | 951.77 Million JPY | 44.59% |
| 2010 Q3 | 658.24 Million JPY | 0.0% |
| 2009 Q4 | 1.41 Billion JPY | 0.0% |
| 2009 Q1 | 1.29 Billion JPY | 0.0% |
| 2009 Q2 | 1.57 Billion JPY | 22.01% |
| 2009 FY | 1.41 Billion JPY | 166.47% |
| 2008 FY | 529.43 Million JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -2502700.0% |
| Ansell Limited | 855.59 Million USD | -1362.607% |
| Ansell Limited | 857.2 Million USD | -1359.869% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -55737.248% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -59775395.582% |
| Psykey, Inc. | 1.01 Million USD | -1238174.292% |
| ConvaTec Group Plc | 1.31 Billion USD | -854.869% |
| ConvaTec Group Plc | 1.31 Billion USD | -853.52% |
| Encision Inc. | 1.33 Million USD | -938542.456% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -541932.653% |
| Innovative MedTech Inc. | 1.87 Million USD | -666167.353% |
| LifePoint, Inc. | 446.74 Thousand USD | -2801081.896% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -231890.689% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -571576.565% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -5157249.862% |
| SmileDirectClub, Inc. | 871.79 Million USD | -1335.426% |
| Sector 10, Inc. | 164 Thousand USD | -7630387.805% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | -1756.644% |
| SheerVision, Inc. | 75 Thousand USD | -16685233.333% |
| United Health Products, Inc. | 755.98 Thousand USD | -1655215.091% |
| Vasamed, Inc. | 23.45 Thousand USD | -53364505.544% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | -452098.297% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -1582950.706% |